Osren Healthcare Private Limited

Osren Healthcare Private Limited

Healthcare company offering wellness products for arthritis, pain, infertility, and urological complications.
2020 | Delhi (India) | Active

Last Updated:

December 12, 2024
HomeCompanyOsren Healthcare Private Limited

Who are the key members and board of directors at Osren Healthcare?

Board Members(2)

NameDesignationAppointment DateStatus
Dinesh Mendiratta In Director 07-Sep-2020Current
Vandana In Director 07-Sep-2020Current

Financial Performance of Osren Healthcare.

Osren Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 359.81% increase. The company also saw a substantial improvement in profitability, with a 3003.59% increase in profit. The company's net worth Soared by an impressive increase of 11.05%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
359.81%
Revenue from Operations
359.81%
Total Assets
66.27%
Profit or Loss
3003.59%
Net Worth
11.05%
EBITDA
152.77%

Charges (Loans)

Open Charges

₹1.21 M

LenderAmountStatus

Hdfc Bank Limited

Creation Date: 16 Sep 2023
₹1.21 MOpen

How Many Employees Work at Osren Healthcare?

Unlock and access historical data on people associated with Osren Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Osren Healthcare

Recent activity within the organization

  • Annual General Meeting

    Osren Healthcare Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Osren Healthcare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

    31 Mar 2024

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.21 M with Charge ID 100820969 was registered on 16 Sep 2023.

    16 Sep 2023

  • Director Appointment

    Vandana was appointed as a Director was appointed as a Director on 07 Sep 2020 & has been associated with this company since 4 years 4 months .

    07 Sep 2020

  • Director Appointment

    Dinesh Kumar Mendiratta was appointed as a Director was appointed as a Director on 07 Sep 2020 & has been associated with this company since 4 years 4 months .

    07 Sep 2020

  • Company Incorporation

    Osren Healthcare Private Limited was registered on 07 Sep 2020 with Roc Delhi & aged 4 years 4 months as per MCA records.

    07 Sep 2020

Frequently asked questions

  • Osren Healthcare Private Limited was incorporated on 07 Sep 2020.

  • The authorized share capital of Osren Healthcare Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Osren Healthcare Private Limited.

    • Vandana
    • Dinesh Kumar Mendiratta
  • As per Ministry of Corporate Affairs (Mca), the registered address of Osren Healthcare Private Limited is Shop No-F-28 Community Centre Sheikh Sarai, Phase - I India, New Delhi, 110017.

  • The corporate identification number (CIN) of Osren Healthcare Private Limited is U74999DL2020PTC369399 and the company number is 369399 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Osren Healthcare Private Limited is https://www.osren.in

  • According to the financial reports for the fiscal year 2022, the revenue trend for Osren Healthcare Private Limited has risen by 359.81%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Osren Healthcare Private Limited has experienced an upsurge of 11.05%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Osren Healthcare Private Limited amount to ₹ 1.21 M.

  • The most recent Balance Sheet for Osren Healthcare Private Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Drug Formulation & Development